Constantine Davides
Stock Analyst at Citizens
(0.87)
# 3,934
Out of 5,172 analysts
120
Total ratings
25.23%
Success rate
-23.48%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $18.01 | +33.26% | 14 | Feb 23, 2026 | |
| PGNY Progyny | Upgrades: Market Outperform | $30 | $18.13 | +65.47% | 4 | Jan 20, 2026 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $28.16 | +34.94% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $2.58 | +287.60% | 12 | Jan 6, 2026 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $81.02 | +50.58% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $21.24 | +45.95% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $5.99 | +300.67% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $24.07 | +99.42% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $99.28 | +51.09% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $11.67 | - | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $6.15 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.43 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $73.86 | +52.99% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $30.78 | -15.53% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $176.79 | +40.28% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $20.34 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $9.18 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.03 | +409.71% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.98 | +12,655.10% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $23.28 | -35.57% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $21.70 | +3.69% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.43 | +147.81% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.91 | +1,430.72% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.74 | +48,647.46% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.16 | +279,210.34% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.80 | +4,918.82% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.19 | +3,106.84% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.20 | +66,566.67% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $597,600 → $298,800 | $2.62 | +11,404,480.15% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.20 | +43,267.35% | 2 | Sep 23, 2022 |
AMN Healthcare Services
Feb 23, 2026
Maintains: Market Outperform
Price Target: $22 → $24
Current: $18.01
Upside: +33.26%
Progyny
Jan 20, 2026
Upgrades: Market Outperform
Price Target: $30
Current: $18.13
Upside: +65.47%
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $28.16
Upside: +34.94%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $2.58
Upside: +287.60%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $81.02
Upside: +50.58%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $21.24
Upside: +45.95%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $5.99
Upside: +300.67%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $24.07
Upside: +99.42%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $99.28
Upside: +51.09%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.67
Upside: -
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $6.15
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.43
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $73.86
Upside: +52.99%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $30.78
Upside: -15.53%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $176.79
Upside: +40.28%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $20.34
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.18
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.03
Upside: +409.71%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.98
Upside: +12,655.10%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $23.28
Upside: -35.57%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $21.70
Upside: +3.69%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.43
Upside: +147.81%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.91
Upside: +1,430.72%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $0.74
Upside: +48,647.46%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.16
Upside: +279,210.34%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.80
Upside: +4,918.82%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.19
Upside: +3,106.84%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.20
Upside: +66,566.67%
Sep 28, 2022
Maintains: Buy
Price Target: $597,600 → $298,800
Current: $2.62
Upside: +11,404,480.15%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.20
Upside: +43,267.35%